LeeSRosenMD
Hematology • Santa Monica, CAMyeloproliferative Disorder Hematology-Oncology
Professor, Medicine, University of California Los Angeles David Geffen SOM
Dr. Rosen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2020 Santa Monica Blvd., Suite 600
Santa Monica, CA 90404Phone+1 310-829-5471Fax+1 310-829-5471- Is this information wrong?
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1993 - 1996- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1990 - 1993
Baylor College of MedicineClass of 1990
Certifications & Licensure
CA State Medical License 1991 - 2025- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 2011
- Super Doctor SuperDoctors.com
Clinical Trials
- Tocladesine in Treating Patients With Recurrent or Progressive Metastatic Colorectal Cancer Start of enrollment: 2001 Apr 01
- Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2000 Dec 01
- Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors Start of enrollment: 2001 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Correction to: A tumor-selective adenoviral vector platform induces transient antiphospholipid antibodies, without increased risk of thrombosis, in phase 1 clinical st...Danny N Khalil, Isabel Prieto González-Albo, Lee Rosen, Tom Lillie, Andrea Stacey, Lola Parfitt, Gerald A Soff> ;Investigational New Drugs. 2023 Jun 1
- 3 citationsA tumor-selective adenoviral vector platform induces transient antiphospholipid antibodies, without increased risk of thrombosis, in phase 1 clinical studies.Danny N Khalil, Isabel Prieto González-Albo, Lee Rosen, Tom Lillie, Andrea Stacey, Lola Parfitt, Gerald A Soff> ;Investigational New Drugs. 2023 Apr 1
- 24 citationsEfficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion-Positive Lung Cancers.Alexander Drilon, Daniel S W Tan, Ulrik N Lassen, Serge Leyvraz, Yongmei Liu, Jyoti D Patel, Lee Rosen, Benjamin Solomon, Ricarda Norenberg, Laura Dima, Nicoletta Breg...> ;JCO Precision Oncology. 2022 Jan 1
- Join now to see all
Professional Memberships
- Fellow
- Member
- Member
- Member
Other Languages
- Hebrew, Spanish
Hospital Affiliations
Providence Saint John's Health CenterSanta Monica, California
UCLA Medical Center-Santa MonicaSanta Monica, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
